• English
  • Eesti

    Estonian medicinal products market in second quarter 2014

    Printer-friendly version

    In the second quarter of 2014 the human and veterinary medicinal products market in wholesale prices was 66.3 million Euros which shows almost 7.5% increase comparing to previous year’s same period.

    Human medicinal products market was 62.9 million Euros which shows 7.3% increase.

    Sales to general pharmacies covered 69% and sales to hospital pharmacies 30% of total wholesale turnover. Sales to other institutions, i.e. state and scientific institutions was modest, being 1% of total sales.

    The proportion of prescription sales was 86% which comparing to over the counter sales (13%) and hospital package sales (1%) covered most of the medicinal products market turnover in second quarter 2014.

    Based on ATC classification, antineoplastic and immunomodulating drugs had the biggest turnover (20%), followed by cardiovascular drugs (13%) and alimentary tract and metabolism medicines (12%).

    The Estonian veterinary medicinal products market was 3.3 million Euros in wholesale prices in the second quarter of 2014. Compared to the second quarter in 2013, the turnover increased 10.2%.

    Almost 89% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 4.5% to the general pharmacies, 4.5% to other institutions (generally state- and scientific institutions) and 2% to the veterinary pharmacies.

    The most sold medicines by turnover were anti-infectives (QJ) 33%, immunologicals 28% and antiparasitic products 18%.

    Human medicines were sold to general and hospital pharmacies as well as to other institutions by 28 wholesalers. There were 9 wholesalers who sold veterinary medicinal products.